Research programme: HIV gp41 inhibitors - Whitehead Institute for Biomedical Research/Howard Hughes

Drug Profile

Research programme: HIV gp41 inhibitors - Whitehead Institute for Biomedical Research/Howard Hughes

Alternative Names: D-peptide inhibitors; HIV gp42 inhibitors - Whitehead Institute/Hughes Medical Institute/Massachusetts Insitute of Technol; IQN17

Latest Information Update: 30 Apr 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial sources
  • Class
  • Mechanism of Action HIV envelope protein gp41 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported HIV infections

Most Recent Events

  • 19 Nov 1999 A study has been added to the antimicrobial activities section
  • 04 Oct 1999 New profile
  • 04 Oct 1999 This research is available for licensing (http://www.hhmi.org/new/kim.htm)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top